Hyderabad Telangana, India

Sesha Reddy Yarraguntla

USPTO Granted Patents = 2 


Average Co-Inventor Count = 9.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Sesha Reddy Yarraguntla

Introduction

Sesha Reddy Yarraguntla is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the pharmaceutical field, particularly in the development of novel crystalline forms of various compounds. With a total of two patents to his name, Yarraguntla's work is recognized for its potential impact on drug formulation and delivery.

Latest Patents

Yarraguntla's latest patents include the development of crystalline forms of vilazodone hydrochloride and vilazodone free base. The first patent relates to both crystalline and amorphous forms of vilazodone hydrochloride, along with amorphous solid dispersions that utilize pharmaceutically acceptable carriers. Additionally, this patent outlines a process for preparing form I of vilazodone free base. His second patent focuses on the solid forms of pemetrexed, providing polymorphs and amorphous forms of pemetrexed or its pharmaceutical acceptable salts, along with the processes for their production.

Career Highlights

Sesha Reddy Yarraguntla is currently associated with Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its innovative drug development. His work at the company has allowed him to contribute to advancements in pharmaceutical sciences, particularly in the area of solid forms of drugs.

Collaborations

Yarraguntla has collaborated with several professionals in his field, including Raghavendracharyulu Venkata Palle and Sekhar Munaswamy Nariyam. These collaborations have further enhanced the research and development efforts within the pharmaceutical sector.

Conclusion

Sesha Reddy Yarraguntla's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing drug formulation technologies. His work continues to influence the industry and improve therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…